CYXO — Cyxone AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual balance sheet for Cyxone AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	R2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	61.8	56.3	29.4	29.2	17.5
Net Total Accounts Receivable
Net Total Receivables	1.25	0.395	2.1	0.633	0.501
Prepaid Expenses
Total Other Current Assets
Total Current Assets	63.3	57.3	32.2	30.4	18.5
Net Property, Plant And Equipment	—	—	—	1.65	1.14
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	75.1	72.2	46.1	52.5	43.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.38	5.05	6.9	4.86	4.62
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.38	5.05	6.9	5.58	4.69
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	71.7	67.1	39.2	46.9	39
Total Liabilities & Shareholders' Equity	75.1	72.2	46.1	52.5	43.7
Total Common Shares Outstanding